Delivery Order SPE2DB22D3016-SPE2DB24FAUX1
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,025.21 firm fixed-price contract is for the delivery of 4,564,428,298 units of Duloxetine Hydrochloride Delayed-Release 60 milligram capsules. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Duloxetine Hydrochloride delayed-release capsules. The contract has a ceiling value of $6,174.99 and an ultimate completion date of September 18, 2024. It is a firm fixed-price contract for the delivery of this prescription medication. The contract is not set aside for any specific business category. AmerisourceBergen,...
- This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Duloxetine HCl delayed-release 60 mg capsules in quantities of 90s. The contract has a completion date of January 26, 2024 and a potential value of $7,091.80. Amerisourcebergen Drug Corp, as a for-profit prime contractor, is providing these pharmaceutical products through its Corporate Office division located in Conshohocken, Pennsylvania. This order is...
- This is a Delivery Order federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,268.15, is for the delivery of 4,567,363,922 units of Duloxetine HCL DR 60 mg capsules. The contract has a period of performance through February 25, 2025 and is a Firm Fixed Price contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,172.84, is for the supply of 4,567,278,594 units of Duloxetine HCL DR 60 MG capsules. The award is a Firm Fixed Price delivery order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,564,146 units of Duloxetine HCL DR 60 MG capsules. The order, valued at $2,208.48, has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp is the prime contractor on a single award indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through...
- This is a $1,754.34 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for 4,566,915,244 units of Duloxetine HCl delayed-release 60 mg capsules. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of Duloxetine Hydrochloride delayed-release capsules, 60 milligrams, with a ceiling value of $1,590.29. The contract is a firm-fixed-price delivery order, with a period of performance ending on June 5, 2025. This contract is not set-aside and was competitively...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Duloxetine HCl DR 40 mg capsules. The contract has a ceiling value of $1,022.54 and a performance period extending through June 18, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $9,244.48 firm fixed price delivery order is for the supply of 4,564,097,792 units of Duloxetine Hydrochloride delayed-release 40 mg capsules. The award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAUX1Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of 4,564,530,932 capsules of Duloxetine Hydrochloride delayed-release 60 mg. The fixed-price contract has a ceiling value of $31,461.28 and a completion date of May 8, 2024. Amerisourcebergen, a major pharmaceutical distributor, does not have a small business set-aside designation for this award. The contract is issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.5k | 5/7/24 |